FEMS Microbiol Lett 2010,303(1):61–68.PubMedCrossRef 20. Humtsoe JO, Kim JK, Xu Y, Keene DR, Höök M, Lukomski S, Wary KK: A streptococcal collagen-like protein interacts with the α 2 β 1 integrin EVP4593 and induces intracellular signaling. J Biol Chem 2005,280(14):13848–13857.PubMedCrossRef 21. Caswell CC, Barczyk M, Keene DR, Lukomska E, Gullberg DE, Lukomski S: Identification

of the first prokaryotic collagen sequence motif that mediates binding to human collagen receptors, integrins α 2 β 1 and α 11 β 1 . J Biol Chem 2008,283(52):36168–36175.PubMedCrossRef 22. Caswell CC, Lukomska E, Seo NS, Höök M, Lukomski S: Scl1-dependent internalization of group A Streptococcus via direct interactions with the α 2 β 1 integrin

enhances pathogen survival and re-emergence. Mol Microbiol 2007,64(5):1319–1331.PubMedCrossRef 23. Gao Y, Liang C, Zhao R, Lukomski S, Han R: The Scl1 of M41-type group A Streptococcus binds the high-density lipoprotein. FEMS Microbiol Lett 2010,309(1):55–61.PubMed 24. Påhlman LI, Marx PF, Morgelin M, Lukomski S, Meijers JCM, Herwald H: Thrombin-activatable fibrinolysis inhibitor binds to Streptococcus pyogenes by interacting with collagen-like proteins A and B. J Biol Chem 2007,282(34):24873–24881.PubMedCrossRef 25. Caswell C, Han R, Hovis K, Ciborowski P, Keene D, PRI-724 in vitro Marconi R, Lukomski S: The Scl1 protein of M6-type group A Streptococcus binds the human complement regulatory protein, factor H, and inhibits the alternative pathway of complement. Mol Microbiol 2008,67(3):584–596.PubMedCrossRef 26. Reuter M, Caswell CC, Lukomski S, Zipfel PF: Binding of the human complement regulators CFHR1 and factor H by streptococcal collagen-like protein 1 (Scl1) via their conserved C termini allows control of the complement cascade at multiple levels. J Biol Chem 2010,285(49):38473–38485.PubMedCrossRef 27. Han R, Caswell CC, Lukomska E, Keene DR, Pawlowski M, Bujnicki JM, Kim JK, Lukomski S: Binding of the low-density lipoprotein by streptococcal collagen-like protein

Scl1 of Streptococcus pyogenes . Mol Microbiol 2006,61(2):351–367.PubMedCrossRef 28. Lembke C, Podbielski A, Hidalgo-Grass C, Jonas L, Hanski E, Kreikemeyer B: Characterization of biofilm formation by clinically relevant serotypes of group A streptococci. Appl Environ Microbiol 2006,72(4):2864–2875.PubMedCrossRef PtdIns(3,4)P2 29. Lukomski S, Sreevatsan S, Amberg C, Reichardt W, Woischnik M, Podbielski A, Musser JM: Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. J Clin Invest 1997, 99:2574–2580.PubMedCrossRef 30. Donlan RM: Biofilms: SRT1720 research buy microbial life on surfaces. Emerg Infect Dis 2002,8(9):881–890.PubMedCrossRef 31. Kania RE, Lamers GE, Vonk MJ, Huy PT, Hiemstra PS, Bloemberg GV, Grote JJ: Demonstration of bacterial cells and glycocalyx in biofilms on human tonsils.